Worcester, MA, United States of America

Qing Xie

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Massachusetts. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qing Xie. Retrieved from https://idiyas.com/inventor/qing-xie-fblq2cna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qing Xie: Innovator in Gene Therapy

Introduction

Qing Xie is a prominent inventor based in Worcester, MA (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of spinal muscular atrophy. Her innovative work has the potential to change the lives of many individuals affected by this condition.

Latest Patents

Qing Xie holds a patent for her groundbreaking invention titled "Gene Therapy for Spinal Muscular Atrophy." This patent represents her commitment to advancing medical science and improving patient outcomes through innovative therapeutic approaches.

Career Highlights

Qing Xie is affiliated with the University of Massachusetts, where she conducts her research and development. Her work at the university has positioned her as a leader in the field of gene therapy, contributing to both academic knowledge and practical applications in medicine.

Collaborations

Throughout her career, Qing Xie has collaborated with notable colleagues, including Jun Xie and Guangping Gao. These partnerships have fostered a collaborative environment that enhances research and innovation in gene therapy.

Conclusion

Qing Xie's contributions to gene therapy exemplify her dedication to scientific advancement and patient care. Her work continues to inspire future innovations in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…